Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing

PHASE3CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Idiopathic Pulmonary Arterial HypertensionCardiomyopathy
Interventions
DRUG

Nitric Oxide for inhalation

Nitric Oxide (NO) for inhalation, given at 80ppm over 10 minutes using an INOvent® delivery system

DRUG

Oxygen

100% oxygen (O2) for inhalation, given at 80ppm over 10 minutes using an INOvent® delivery system

DRUG

Nitric Oxide plus Oxygen

Nitric Oxide (NO) for inhalation plus oxygen, given at 80ppm over 10 minutes using an INOvent® delivery system

Trial Locations (18)

10032

New York Presbyterian Hospital, New York

29425

The Medical University of South Carolina, Charleston

43205

Columbus Children's Hospital, Columbus

45229

Cincinnati Children's Hospital, Cincinnati

63110

St. Louis Children's Hospital, St Louis

80218

The Children's Hospital, Denver

94304

Lucile Salter Packard Children's Hospital at Stanford, Stanford

02115

Children's Hospital Boston, Boston

Unknown

CHU Timone - Département de cardiologie, Marseille

Hôpital d'Enfants, Nancy

Hôpital NECKER - Enfants Malades, Paris

Beatrix Children's Hospital / University Hospital Groningen, Groningen

Hospital Sant Joan de Déu de Barcelona, Barcelona

Unidad de Cardiologia Infantil - Hospital Vall d'Hebrón, Barcelona

Hospital Gregorio Maranon, Madrid

Instituto Pediátrico del Corazón - Hospital Materno Infatil Doce de Octubre, Madrid

Royal Brompton Hospital, London

Southampton University Hospitals Trust - Wessex Cardiothoracic Centre, Southampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY